Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BIM 23042 Acetate [D-Nal-Cys-Tyr- D-Trp-Lys-Val-Cys-Nal-NH2] is a selective antagonist of neuromedin B.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 298.00 | |
5 mg | In stock | $ 671.00 | |
10 mg | In stock | $ 997.00 | |
25 mg | In stock | $ 1,480.00 | |
50 mg | In stock | $ 1,990.00 | |
100 mg | In stock | $ 2,690.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 1,280.00 |
Description | BIM 23042 Acetate [D-Nal-Cys-Tyr- D-Trp-Lys-Val-Cys-Nal-NH2] is a selective antagonist of neuromedin B. |
In vitro | BIM 23042 competitively inhibited neuromedin B-induced endpoint in huNMBR cells. BIM 23042 has a l00-fold greater affinity for BB1 receptors than BB2 receptors. |
Synonyms | BIM 23042 Acetate (111857-96-6 Free base) |
Molecular Weight | 1252.5 |
Formula | C65H77N11O11S2 |
CAS No. | T21661L |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 65 mg/ml (51.9 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BIM 23042 Acetate T21661L Others 111857-96-6 BIM 23042 Acetate (111857-96-6 Free base) BIM-23042 Acetate BIM23042 Acetate 111857-96-6 Free base inhibitor inhibit